Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats

Experimental Eye Research

Volumn 86, Issue 2, 2008, Pages 375-382

  Zhu, Bijun ^a   Wang, Weijun ^a   Gu, Qing ^a   Xu, Xun ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

diabetic retinopathy; erythropoietin; high performance liquid chromatography; rat

Indexed keywords

ERYTHROPOIETIN RECEPTOR; GLUTAMIC ACID; RECOMBINANT ERYTHROPOIETIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; GLIA CELL; MALE; METAMORPHOSIS; MITOCHONDRION; NONHUMAN; OSCILLATORY POTENTIAL; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; RETINA NERVE CELL; STREPTOZOCIN DIABETES;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; ERYTHROPOIETIN, RECOMBINANT; GLUTAMIC ACID; MICROSCOPY, ELECTRON; MITOCHONDRIA; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; RETINA; RETINAL GANGLION CELLS;

EID: 39149136857     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.11.010     Document Type: Article

References (34)

1. Algvere P. Clinical studies on the oscillatory potentials of the human electroretinogram with special reference to the scotopic b-wave. Acta Ophthalmol. (Copenh.) 46 5 (1968) 993-1024
2. Amos A., et al. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med. 14 suppl. 5 (1997) S1-S58
3. Barber A.J. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 283-290
4. Brines M.L., et al. From the cover: erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10526-10531
5. Campana W.M., and Myers R.R. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J. (2001) 10.1096/fj.00-0857fje
6. Creese I., et al. The classic fication of dopamine receptors: Relationship to radioligand binding. Annu. Rev. Neurosci. 6 (1983) 43-71
7. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 412 6847 (2001) 641-647
8. Duarte A.I., et al. Oxidative stress affects synaptosomal-aminobutyric acid and glutamate transport in diabetic rats: the role of insulin. Diabetes 53 (2004) 2110-2116
9. Erbayraktar S., et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6741-6746
10. Gardner T.W., et al. Diabetic retinopathy: more than meets the eye. Surv. Ophthalmol. 47 (2002) S253-S262
11. Grimm C., et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8 (2002) 718-724
12. Hotta N., et al. Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats. Exp. Physiol. 80 (1995) 981-989
13. International Standardization Committee. Standard for clinical electroretinography. Arch. Ophthalmol. 107 (1989) 816
14. Juen S., and Kieselbach G.F. Electrophysiological changes in juvenile diabetics without retinopathy. Arch. Ophthalmol. 108 (1990) 372-375
15. Junk A.K., et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 99 16 (2002) 10659-10664
16. Kawakami M., et al. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276 (2001) 39469-39475
17. Lieth E., et al. Retinal neurodegeneration: early pathology in diabetes. Clin. Exp. Ophthalmol. 28 (2000) 3-8
18. Lorenzi M., and Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44 (2001) 791-804
19. National Diabetes Data Group. Diabetes in America. second ed. (1995), U.S. Govt. Printing Office, Washington NIH Publ. No. 95-1468
20. Ogden T.E. The oscillatory waves of the primate electroretinogram. Vis. Res. 13 (1973) 1059-1074
21. Rosenbaum D.M., et al. Erythropoietin acts as an endogenous neuroprotective agent in retinal ischemia. Invest. Ophthalmol. Vis. Sci. 43 19 (2002) 1996-1997
22. Rossert J., and Eckardt K.U. Erythropoietin receptors: their role beyond erythropoiesis. Nephrol. Dial. Transpl. 20 6 (2005) 1025-1028
23. Ruscher K., et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22 (2002) 10291-10301
24. Sadamoto Y., et al. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253 (1998) 26-32
25. Schutte M., and Werner P. Redistribution of glutathione in the ischemic rat retina. Neurosci. Lett. 246 1 (1998) 53-56
26. Sirén A.L., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 4044-4049
27. Sitges M., et al. Simultaneous action of MK-801 (dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings. Brain Res. 854 (2000) 48-56
28. Tzekov R., and Arden G.B. The electroretinogram in diabetic retinopathy. Surv. Ophthalmol. 44 (1999) 53-60
29. Wachtmeister L., and Dowling J.E. The oscillatory potentials of the mudpuppy retina. Invest. Ophthalmol. Vis. Sci. 17 (1978) 1176-1188
30. Weishaupt J.H., et al. Effect of Erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 45 15 (2004) 1514-1522
31. Wilkinson C.P., et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110 9 (2003) 1677-1682
32. Wurziger K., et al. On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vis. Res. 41 8 (2001) 1091-1101
33. Yamasaki M., et al. Erythropoietin prevents glutamate-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 45 (2004) E-Abstract 855
34. Yonemura D., et al. Clinical importance of the oscillatory potential in the human ERG. Acta Ophthalmol. Suppl. 70 (1962) 115-123